Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Changes in plasma free fatty acids associated with Type-2 Diabetes

Tools
- Tools
+ Tools

Sobczak, Amélie I. S., Blindauer, Claudia A. and Stewart, Alan (2019) Changes in plasma free fatty acids associated with Type-2 Diabetes. Nutrients, 11 (9). e2022. doi:10.3390/nu11092022

[img]
Preview
PDF
WRAP-changes-plasma-free-fatty-acids-type-2-diabetes-Blindauer-2019.pdf - Published Version - Requires a PDF viewer.
Available under License Creative Commons Attribution 4.0.

Download (1359Kb) | Preview
Official URL: https://doi.org/10.3390/nu11092022

Request Changes to record.

Abstract

Type 2 diabetes mellitus (T2DM) is associated with increased total plasma free fatty acid (FFA) concentrations and an elevated risk of cardiovascular disease. The exact mechanisms by which the plasma FFA profile of subjects with T2DM changes is unclear, but it is thought that dietary fats and changes to lipid metabolism are likely to contribute. Therefore, establishing the changes in concentrations of specific FFAs in an individual’s plasma is important. Each type of FFA has different effects on physiological processes, including the regulation of lipolysis and lipogenesis in adipose tissue, inflammation, endocrine signalling and the composition and properties of cellular membranes. Alterations in such processes due to altered plasma FFA concentrations/profiles can potentially result in the development of insulin resistance and coagulatory defects. Finally, fibrates and statins, lipid-regulating drugs prescribed to subjects with T2DM, are also thought to exert part of their beneficial effects by impacting on plasma FFA concentrations. Thus, it is also interesting to consider their effects on the concentration of FFAs in plasma. Collectively, we review how FFAs are altered in T2DM and explore the likely downstream physiological and pathological implications of such changes.

Item Type: Journal Article
Divisions: Faculty of Science > Chemistry
SWORD Depositor: Library Publications Router
Journal or Publication Title: Nutrients
Publisher: MDPI
ISSN: 2072-6643
Official Date: 28 August 2019
Dates:
DateEvent
28 August 2019Published
24 August 2019Accepted
Volume: 11
Number: 9
Article Number: e2022
DOI: 10.3390/nu11092022
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Open Access
RIOXX Funder/Project Grant:
Project/Grant IDRIOXX Funder NameFunder ID
RPG-2017-214 Leverhulme TrustUNSPECIFIED
PG/15/9/31270 ; FS/15/42/3155 British Heart FoundationUNSPECIFIED
Related URLs:
  • https://creativecommons.org/licenses/by/...

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics

twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us